Rekrutierung

Eingeschlossene Patienten: 19.710 (Stand 03. August 2020)
Amgevita® (Adalimumab)	83
Benepali® (Etanercept)	714
Cimzia® (Certolizumab)	928
Enbrel® (Etanercept)	2865
Erelzi® (Etanercept)	273
Flixabi® (Infliximab)	8
Hulio® (Adalimumab)	37
Humira® (Adalimumab)	2903
Hyrimoz® (Adalimumab)	65
Idacio® (Adalimumab)	2
Imraldi® (Adalimumab)	85
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	132
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1458
Olumiant® (Baricitinib)	407
Orencia® (Abatacept)	838
Remicade® (Infliximab)	762
Remsima® (Infliximab)	10
Rinvoq® (Upadacitinib)	47
Rixathon® (Rituximab)	12
RoActemra® (Tocilizumab)	1330
Simponi® (Golimumab)	446
Xeljanz® (Tofacitinib)	297
Zessly® (Infliximab)	2
Kontrollen	5901